Применение арглабина в клинике

The results of 3 phases of clinical trials of Arglabine agent for patients with disseminated cancer of various localizations and its administration in combined modality treatment for patients with cancers of liver, esophagus and locally advanced and disseminated breast cancer have been presented. Not only cytostatic effect but also chemo-and radio-sensitizing effects of Arglabine have been found.